Restorative valve therapy by endogenous tissue restoration: tomorrow’s world? Reflection on the EuroPCR 2017 session on endogenous tissue restoration

EuroIntervention 2017;13:AA68-AA77. DOI: 10.4244/EIJ-D-17-00509

Patrick  W. Serruys
Patrick W. Serruys1*, MD, PhD; Yosuke Miyazaki2, MD, PhD; Athanasios Katsikis3, MD, PhD; Mohammad Abdelghani4, MD; Martin B. Leon5, MD; Renu Virmani6, MD; Thierry Carrel7, MD; Martijn Cox8, PhD; Yoshinobu Onuma2,9, MD, PhD; Osama I.I. Soliman2,9, MD, PhD
1. Imperial College London, London, United Kingdom; 2. Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands; 3. Cardiology Department, 401 General Military Hospital of Athens, Athens, Greece; 4. Department o

The current standard of treatment of valvular diseases with severe functional and/or clinical consequences is the repair or replacement of the valve, which is usually surgical or, in specific scenarios, percutaneous. The avai

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

bioresorbableendogenous tissue restorationprostheticvalvesxeltis
Interventions for valvular diseaseOther valvular and structural interventions
Read next article
Left atrial appendage occlusion

Latest news